Oliver N - Search Results

1

Silverman JA, Oliver N, Andrew T, Li T. Silverman JA, et al. Among authors: oliver n. Antimicrob Agents Chemother. 2001 Jun;45(6):1799-802. doi: 10.1128/AAC.45.6.1799-1802.2001. Antimicrob Agents Chemother. 2001. PMID: 11353628 Free PMC article.

2

A series of spirocyclic analogues as potent inhibitors of bacterial phenylalanyl-tRNA synthetases.

Yu XY, Finn J, Hill JM, Wang ZG, Keith D, Silverman J, Oliver N. Yu XY, et al. Among authors: oliver n. Bioorg Med Chem Lett. 2004 Mar 8;14(5):1339-42. doi: 10.1016/j.bmcl.2003.11.081. Bioorg Med Chem Lett. 2004. PMID: 14980694

3

A series of heterocyclic inhibitors of phenylalanyl-tRNA synthetases with antibacterial activity.

Yu XY, Finn J, Hill JM, Wang ZG, Keith D, Silverman J, Oliver N. Yu XY, et al. Among authors: oliver n. Bioorg Med Chem Lett. 2004 Mar 8;14(5):1343-6. doi: 10.1016/j.bmcl.2003.11.082. Bioorg Med Chem Lett. 2004. PMID: 14980695

4

Cross-resistance analysis of human immunodeficiency virus type 1 variants individually selected for resistance to five different protease inhibitors.

Tisdale M, Myers RE, Maschera B, Parry NR, Oliver NM, Blair ED. Tisdale M, et al. Among authors: oliver nm. Antimicrob Agents Chemother. 1995 Aug;39(8):1704-10. doi: 10.1128/AAC.39.8.1704. Antimicrob Agents Chemother. 1995. PMID: 7486905 Free PMC article.

5

Biological and biochemical characterization of clinical isolates of herpes simplex virus type 2 resistant to acyclovir.

Oliver NM, Collins P, Van der Meer J, Van't Wout JW. Oliver NM, et al. Antimicrob Agents Chemother. 1989 May;33(5):635-40. doi: 10.1128/AAC.33.5.635. Antimicrob Agents Chemother. 1989. PMID: 2546486 Free PMC article.

6

Sensitivity monitoring of herpes simplex virus isolates from patients receiving acyclovir.

Collins P, Oliver NM. Collins P, et al. Among authors: oliver nm. J Antimicrob Chemother. 1986 Oct;18 Suppl B:103-12. doi: 10.1093/jac/18.supplement_b.103. J Antimicrob Chemother. 1986. PMID: 3025149

7

Characterization of a DNA polymerase mutant of herpes simplex virus from a severely immunocompromised patient receiving acyclovir.

Collins P, Larder BA, Oliver NM, Kemp S, Smith IW, Darby G. Collins P, et al. Among authors: oliver nm. J Gen Virol. 1989 Feb;70 ( Pt 2):375-82. doi: 10.1099/0022-1317-70-2-375. J Gen Virol. 1989. PMID: 2543743

8

Acyclovir-resistant herpes simplex virus infection due to altered DNA polymerase.

Parker AC, Craig JI, Collins P, Oliver N, Smith I. Parker AC, et al. Among authors: oliver n. Lancet. 1987 Dec 19;2(8573):1461. doi: 10.1016/s0140-6736(87)91157-3. Lancet. 1987. PMID: 2892018 No abstract available.

9

Comparison of the in vitro and in vivo antiherpes virus activities of the acyclic nucleosides, acyclovir (Zovirax) and 9-[(2-hydroxy-1-hydroxymethylethoxy)methyl]guanine (BWB759U).

Collins P, Oliver NM. Collins P, et al. Among authors: oliver nm. Antiviral Res. 1985 Jun;5(3):145-56. doi: 10.1016/0166-3542(85)90047-6. Antiviral Res. 1985. PMID: 2992369

10

Sensitivity of herpes virus isolates from acyclovir clinical trials.

Collins P, Appleyard G, Oliver NM. Collins P, et al. Among authors: oliver nm. Am J Med. 1982 Jul 20;73(1A):380-2. doi: 10.1016/0002-9343(82)90127-9. Am J Med. 1982. PMID: 6285727

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

461 results

Search Page

Filters